Derma Sciences is a pharmaceutical company providing a complete line of products for wound and skin care. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company's traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.

Type
Subsidiary
Parent Company
Integra LifeSciences
HQ
Princeton, US
Founded
1984
Derma Sciences was founded in 1984 and is headquartered in Princeton, US
Report incorrect company information

Key People/Management at Derma Sciences

John E. Yetter

John E. Yetter

CFO & Vice President of Finance
Srini Conjeevaram

Srini Conjeevaram

Director

Derma Sciences Office Locations

Derma Sciences has offices in Fenton, Toronto, Princeton and New York
Princeton, US (HQ)
300 214 Carnegie Center
Fenton, US
145 Cassens Ct
New York, US
800 3rd Ave
Toronto, CA
154 Shorting Rd
Show all (4)
Report incorrect company information

Derma Sciences Financials and Metrics

Summary Metrics

Founding Date

1984

Total Funding

$29.1 m
In total, Derma Sciences had raised $29.1 m. Derma Sciences is a subsidiary of Integra LifeSciences

Derma Sciences Financials

Derma Sciences's revenue was reported to be $84.47 m in FY, 2015 which is a 0.9% increase from the previous period.
Annual
USDFY, 2013FY, 2014FY, 2015

Revenue

79.7 m83.7 m84.5 m

Revenue growth, %

5%1%

Cost of goods sold

50.3 m53.6 m51.7 m

Gross profit

29.4 m30.1 m32.7 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Revenue

22.1 m19.8 m20.9 m20.2 m19.5 m22.6 m22.2 m20.2 m22.2 m21.8 m

Cost of goods sold

14 m12.9 m13.1 m13.8 m12 m14.2 m13.7 m12.5 m13.9 m11.1 m

Gross profit

8 m6.9 m7.8 m6.4 m7.5 m8.4 m8.4 m7.7 m8.3 m10.7 m

Gross profit Margin, %

36%35%38%32%39%37%38%38%37%49%
Annual
USDFY, 2013FY, 2014FY, 2015

Cash

6.5 m19.4 m15.8 m

Accounts Receivable

7.3 m8.8 m8.1 m

Inventories

16.5 m13.3 m20.7 m

Current Assets

49.5 m100.8 m71.1 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Cash

5.4 m57.1 m57.1 m43.3 m16.5 m13 m14.4 m11.8 m19 m26 m

Accounts Receivable

8.5 m7.7 m7.9 m7.5 m

Inventories

15.1 m18.1 m17.6 m15 m15.8 m17.5 m18.3 m21.4 m18.3 m14.4 m

Current Assets

53.1 m122.3 m117.1 m110.1 m93.7 m86.3 m78.1 m67.8 m72.6 m69.3 m
Annual
USDFY, 2013FY, 2014FY, 2015

Net Income

(24 m)(39.8 m)(38.1 m)

Inventories

(3 m)2.6 m(9.1 m)

Accounts Payable

574.3 k679.9 k(1.6 m)

Cash From Operating Activities

(17.2 m)12.9 m(3.6 m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

(18.5 m)(10.3 m)(19 m)(30.2 m)(10.6 m)(19.9 m)(28.9 m)(1.8 m)224.8 k(1.2 m)

Inventories

(1.7 m)(2 m)(1.3 m)1 m(3 m)(4.6 m)(5.7 m)(209.3 k)2.5 m3.9 m

Accounts Payable

1.4 m1.1 m89.7 k1.4 m1.3 m1.3 m(310.4 k)(468.9 k)(912.9 k)(876.1 k)

Cash From Operating Activities

(13.6 m)(11.7 m)(15.1 m)(18.9 m)(10.7 m)(18.5 m)(27.3 m)(3.7 m)(4.4 m)(4.6 m)
Show all financial metrics

Derma Sciences Operating Metrics

FY, 2015

Patents (US)

50
Show all operating metrics
Report incorrect company information